Related Experiment Video
Updated: Feb 15, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Clinical Outcomes of Myocardial Bridging versus No Myocardial Bridging in Patients with Apical Hypertrophic
Insights
Myocardial bridging (MB) is more common in apical hypertrophic cardiomyopathy (AHCM) patients, leading to worse symptoms and increased cardiovascular event risk, though not higher mortality.
Area of Science:
- Cardiology
- Cardiovascular Research
- Medical Imaging
Background:
- Apical hypertrophic cardiomyopathy (AHCM) is a distinct form of hypertrophic cardiomyopathy.
- Myocardial bridging (MB) involves the compression of a coronary artery segment during systole.
- The clinical significance of MB in AHCM remains incompletely understood.
Purpose of the Study:
- To investigate the prevalence of myocardial bridging in patients diagnosed with apical hypertrophic cardiomyopathy.
- To evaluate the clinical effects and cardiovascular outcomes associated with myocardial bridging in this patient cohort.
Main Methods:
- Retrospective analysis of angiograms from 212 AHCM patients to identify myocardial bridging.
- Classification of patients into two groups: AHCM with MB and AHCM without MB.
- Review of cardiovascular risk factors, symptoms, cardiovascular events, and mortality.
Main Results:
- Myocardial bridging was identified in 60 of the 212 AHCM patients.
- Patients with MB exhibited significantly higher rates of angina, myocardial infarction-like presentations, and severe angina.
- Cardiovascular event-free survival was significantly lower in AHCM patients with MB compared to those without.
Conclusions:
- Myocardial bridging is associated with more severe symptoms and an increased risk of cardiovascular events in AHCM patients.
- While cardiovascular mortality was similar between groups, MB is an independent risk factor for cardiovascular events in AHCM.
Objective:
To determine the prevalence and clinical effects of myocardial bridging (MB) in patients with apical hypertrophic cardiomyopathy (AHCM).
Methods:
Angiograms from 212 AHCM patients were reviewed to identify MB. The patients were classified into 2 groups: AHCM with and AHCM without MB. We reviewed patient records on cardiovascular (CV) risk factors, symptoms, CV events, and CV mortality.
Results:
In all, 60 patients with MB and 100 without MB were included. Rates of angina (61.7 vs. 40%; p = 0.008), mimicking non-ST-segment elevation myocardial infarction (15 vs. 3%, p = 0.013), and Canadian Cardiovascular Society class III/IV angina (18.3 vs. 4%; p = 0.003) were higher in patients with MB than in those without. Mean follow-up periods (65.5 ± 50.5 vs. 64.4 ± 43.6 months, p = 0.378) and CV mortality (3.3 vs. 1%; p = 0.652) were similar in the 2 groups. Kaplan-Meier estimates demonstrated that CV event-free survival rates were lower in patients with MB than in those without (71.7 vs. 88%; p = 0.022). MB, late gadolinium enhancement, and female sex were independent risk factors for CV events in a multivariate Cox regression analysis adjusted for other risk factors.
Conclusion:
More serious symptoms and a higher risk of CV events were observed in AHCM patients with MB than in those without MB. CV mortality was similar in these 2 groups.
Related Concept Videos
Design Example: Strain Gauge Bridge or Wheatstone Bridge
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Wheatstone Bridge
Thus, for accurate resistance measurements, a...
Bridge rectifier
Operationally, the bridge rectifier allows current flow through two of its diodes during each...
Cross-bridge Cycle
Diels–Alder Reaction Forming Bridged Bicyclic Products: Stereochemistry

